Articles with "carbidopa intestinal" as a keyword



Photo by sxy_selia from unsplash

Problems related to levodopa‐carbidopa intestinal gel treatment in advanced Parkinson's disease

Sign Up to like & get
recommendations!
Published in 2017 at "Brain and Behavior"

DOI: 10.1002/brb3.737

Abstract: Continuous levodopa‐carbidopa intestinal gel (LCIG) diminishes daily “off” time and dyskinesia in patients with advanced Parkinson′s disease (PD). Complications are common with percutaneous endoscopic gastrostomy with a jejunal extension tube (PEG‐J). read more here.

Keywords: levodopa carbidopa; carbidopa intestinal; parkinson disease; advanced parkinson ... See more keywords
Photo by sxy_selia from unsplash

l‐Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior

Sign Up to like & get
recommendations!
Published in 2017 at "Brain and Behavior"

DOI: 10.1002/brb3.848

Abstract: In Parkinson's disease (PD), effects on behavior and cognition of levodopa/carbidopa intestinal gel (LCIG) and subthalamic stimulation (STN‐DBS) and their practical consequences remain controversial. This study was designed to analyze the possible effects of these… read more here.

Keywords: intestinal gel; stimulation; carbidopa intestinal; cognition behavior ... See more keywords
Photo by camstejim from unsplash

Enteral Feeding Using Levodopa‐Carbidopa Intestinal Gel Percutaneous Endoscopic Gastrostomy Tube

Sign Up to like & get
recommendations!
Published in 2017 at "Movement Disorders Clinical Practice"

DOI: 10.1002/mdc3.12490

Abstract: In Parkinson’s disease (PD), dysphagia has a significant influence on nutritional status. When dysphagia is resistant to oral nutrition intervention, enteral nutrition using a percutaneous endoscopic gastrostomy (PEG) can be considered. A levodopa (L-DOPA)-carbidopa intestinal… read more here.

Keywords: endoscopic gastrostomy; percutaneous endoscopic; intestinal gel; carbidopa intestinal ... See more keywords
Photo by camstejim from unsplash

Levodopa‐Carbidopa Intestinal Gel in a Pediatric Parkinsonism‐plus Syndrome

Sign Up to like & get
recommendations!
Published in 2017 at "Movement Disorders Clinical Practice"

DOI: 10.1002/mdc3.12509

Abstract: In Parkinson's disease, levodopa-carbidopa intestinal gel (LCIG) is indicated in control of motor fluctuations, dyskinesias1 and non-motor symptoms. We here report the first case of LCIG pediatric use. Our patient presented with upper limb tremor… read more here.

Keywords: levodopa carbidopa; gel pediatric; carbidopa intestinal; intestinal gel ... See more keywords
Photo by camstejim from unsplash

How Do I Manage Patients With the Levodopa/Carbidopa Intestinal Gel?

Sign Up to like & get
recommendations!
Published in 2019 at "Movement Disorders Clinical Practice"

DOI: 10.1002/mdc3.12701

Abstract: The levodopa carbidopa intestinal gel is a device‐assisted therapy used for the management of fluctuating motor symptoms of Parkinson's disease that are refractory to oral therapy. The approach has demonstrable clinical value, but consideration of… read more here.

Keywords: levodopa carbidopa; manage patients; patients levodopa; carbidopa intestinal ... See more keywords
Photo by des0519 from unsplash

Levodopa‐carbidopa intestinal gel: is the naso‐jejunal phase a redundant convention?

Sign Up to like & get
recommendations!
Published in 2018 at "Internal Medicine Journal"

DOI: 10.1111/imj.13754

Abstract: Levodopa‐carbidopa intestinal gel (LCIG) is an effective treatment for Parkinson disease. Initiating therapy involves an initial naso‐jejunal (NJ) titration phase. The NJ phase is prolonged with significant morbidity. The aim of this study is to… read more here.

Keywords: levodopa carbidopa; phase; carbidopa intestinal; naso jejunal ... See more keywords
Photo by arunwithideas from unsplash

Acute/subacutae demyelinating polyneuropathy in Parkinson's Disease patients on levodopa-carbidopa intestinal gel therapy: systematic review with new case report.

Sign Up to like & get
recommendations!
Published in 2023 at "Neurologia i neurochirurgia polska"

DOI: 10.5603/pjnns.a2023.0001

Abstract: Polyneuropathy (PNP) is a known complication of levodopa-carbidopa intestinal gel (LCIG) therapy of advanced Parkinson's Disease (PD). The overall prevalence of PNP in PD is estimated to be 42.1% (as shown in a review by… read more here.

Keywords: demyelinating polyneuropathy; review; levodopa carbidopa; therapy ... See more keywords